Bactiguard AB

Azerbaijan, Kazakhstan and Uzbekistan - three new countries for Bactiguard

Pressmeddelande   •   Nov 06, 2013 14:44 CET


The Swedish medtech company Bactiguard has signed distributor agreements for three new countries Azerbaijan, Kazakhstan and Uzbekistan. In May 2013 the Company Allmed Group became Bactiguard’s representative in Pakistan and that successful cooperation has now led to that Allmed Group will be introducing the Bactiguard Infection Protection Program in these three new countries.

“We are very pleased with the results in Pakistan since we introduced Bactiguard. Their unique solution for infection protection does not only prevent infections, but also reduce the use of antibiotics and saves health care expenditures. We are confident that hospitals in all these countries will use Bactiguard’s clinically proven solution in order to save lives” says Ejaz Mirza, CEO of Allmed Group.

Allmed Group has Bactiguards complete portfolio for infection control, including urinary, intravenous and respiratory catheters.

Christian Kinch, CEO Bactiguard:

“The success we have had lately with our infection control portfolio in Pakistan is something I am hoping to be the result in Azerbaijan, Kazakhstan and Uzbekistan now with the help of Allmed Group. Health care associated infections (HAI) are the fourth largest cause of death in the world and with the raising number of MRSA in the world, we have noticed an increased awareness for infection control in these countries.”

The Bactiguard® coating has been applied to urinary catheters in the U.S. since 1995 and over 125 million Bactiguard coated catheters have been used in clinical practice all over the world. The Bactiguard technology consists of an extremely thin noble metal coating that reduces bacterial adhesion and is biocompatible.

The company Bactiguard has the vision of becoming the world leader in reducing all device related health care associated infections. Through innovative technology and techniques, we are providing a clinically proven, practical and cost effective solution. The proof of Bactiguard® – over 100.000 patients in clinical studies, 125 million end users.

ALLMED GROUP OF COMPANIES is one of the fastest growing companies working in all its dimensions in pharmaceuticals medical equipment and diagnostics. Our world is shaped by a passion for innovation, commitment to partners and concern for the people in an effort to create healthier communities in the region. For last 25 years our meaningful innovations have improved the quality of life for millions, creating a strong and trusted ALLMED brand with market success all over our regions. We take ownership, deliver as promised, work in teams to deliver superior value for our customers and stakeholders. Everything ALLMED does and represents is about improving, prolonging and saving lives. To be precise “WE CARE FOR LIFE AND WE VALUE YOUR INVESTMENTS.”